Top Small Nanotech Companies to Watch

Top small nanotech companies have stopped selling promise. They now sell filters, coatings and tablets. The timing makes sense. Water rules are getting tougher, corrosion eats billions every year, and plenty of good drugs fail because the body can't absorb them.

Europe offers the clearest example.

According to law firm Hogan Lovells, under Directive (EU) 2024/3019, the recast Urban Wastewater Treatment Directive, pharmaceutical and cosmetics manufacturers must contribute at least 80% of the cost of treatment plants that will eliminate micropollutants from the sewage. Member States have until 31 July 2027 to implement the legislation into their laws. A legal deadline brings buyers, and buyers bring opportunities for innovative nanotechnology startups.

Why small companies secure the initial contracts

Large industrial conglomerates market their nanomaterials among thousands of other products. Small companies focus on the entire company on just one challenge, such as developing a membrane pore, a coating formula, or a method to reduce the size of drug crystals. Such specialization is a strength of those companies. But such specialization is also a weak point of these companies.

The challenges are great. In August 2025, WHO and UNICEF reported that 2.1 billion people still lack safely managed drinking water. NACE International's IMPACT study, as summarized by Engineering.com estimated corrosion to cost the world economy US$2.5 trillion annually, which equals about 3.4% of global GDP. Pharmaceutical industry has its own challenge in the area of poor solubility and bioavailability.

So why do small firms, and not the chemical giants, win the early orders? Speed is one reason. A company with a single product can run a pilot, fix what went wrong and sell the result within one budget cycle.

Water: where nanotechnology in water treatment is already paying off

NX Filtration

NX Filtration is the best documented case. The Dutch company grew out of the University of Twente and is listed on Euronext Amsterdam. It makes hollow fiber nanofiltration membranes with pores fine enough to block PFAS, drug residues and nanoplastics. In its first-half 2026 results, revenue rose 19% to €7.8 million. Order intake jumped 61%, and the order book grew to five times its size a year earlier. Cash stood at €18.4 million against a normalized EBITDA loss of €6.7 million.

The company also won the largest order in its history, from a municipal drinking water plant in Sweden.

"This order demonstrates the effectiveness of our focused regional commercial strategy," said CEO Floris Jan Cuypers.

Management aims for revenue growth of about 50% a year and break-even EBITDA in the medium term. Orders growing faster than revenue is a good sign for water purification technology. It only holds up if deliveries keep pace.

A twelve-month pilot that ended in July 2026 shows where demand is heading. NX Filtration worked with the Eau d'Azur utility, a local university and a regional water agency to test nanofiltration paired with advanced oxidation at the Haliotis plant in Nice. A successor plant is planned at 45 million cubic meters a year.

Innovacarbon

The Italian company Innovacarbon makes carbon nanotube filters that soak up oils, dyes and hydrocarbons. It says the filter material can be regenerated and used again.

CarboNet

Canada's CarboNet sells a flocculant and a coagulant additive. Both slot into existing treatment systems, so customers can start using them without rebuilding anything.

Coral Innovations

Coral Innovations develops NanoMedia products that capture heavy metals, phosphate and organic chemicals. Its bet is that recovering these materials will matter as much as removing them.

Policy risk

Policy can swing both ways. In May 2025 the EPA said it would keep its 4 parts-per-trillion limits for PFOA and PFOS but give utilities until 2031. Administrator Lee Zeldin promised "common-sense flexibility," as Fortune reported from Associated Press. A May 2026 proposal goes further. It would drop limits for PFHxS, PFNA and GenX, and move the PFOA and PFOS deadline for qualifying systems from April 2029 to April 2031, according to Jones Day. When rules loosen in Washington and tighten in Brussels, which small supplier can afford to wait?

Coatings: selling lifetime, not paint

Corrosion is a bill that never stops arriving. Nanocoatings try to shrink it. Market researcher GII Research puts the segment at US$16.55 billion in 2026 and US$26.06 billion by 2033. Read that as a direction, not a fact. It is a vendor forecast.

Nanophyll

Montreal-based Nanophyll, founded in 2015, sells AntiStick for concrete and CuraPhyll for textiles. Its PolyPhyll is a powder coating built for hot, corrosive oil and gas sites.

Smallmatek

Portugal's Smallmatek makes additives that release active agents from tiny nano and micro containers. It also tests the safety of its own materials.

Integran Technologies

Integran Technologies, founded in 1999, uses a nanocrystalline metal platform for coatings and parts. Its customers include aerospace, defense and biomedical firms.

Who buys

The buyer here is a maintenance manager, not a chemist. Approval cycles in aerospace and energy tend to be slow, so the winners will be firms that can pay their way through years of testing before the first big order. Would an asset owner pay more up front if the savings were certified on paper?

Nanotechnology in Healthcare: from theory to tablets

Nanoform

Nanoform, based in Helsinki, shrinks drug crystals to nanoparticle size so medicines dissolve and absorb better. In 2025 it ran bioequivalence trials of one 160 mg enzalutamide tablet meant to replace four 40 mg tablets, reported by forumNordic. The Finnish Medicines Agency then gave it a commercial manufacturing license.

"Our first targeted European market launch is Nanoenzalutamide in 2028," said CEO Edward Hæggström.

Spago Nanomedical

Sweden's Spago Nanomedical takes the opposite route. Its cancer program Tumorad sends a radionuclide to tumors. In May 2026 an independent committee found that the Phase I/IIa trial had met its primary goal of identifying a maximum tolerated dose. Cash was about SEK 25.9 million at the end of March, and first-half net sales were SEK 22 thousand.

CEO Mats Hansen says, "Securing financing for phase IIa remains a clear priority."

The contrast

Nanoform offers the manufacture and formula to the owners of drugs, and hence the income comes earlier before approval of the drug. Spago is the owner of both the science and the risk. One test determines the fate of the business. What is the greater risk to the small business, the science or the time?

Where the risks sit

Competitors of the firm are never the startups. The nanotech firms face competition from the well-established membrane companies, coating companies, and formulating firms. These companies offer the trusted and inexpensive products to order. Capital requirements, dependency on few partners and safety issues of the nanomaterials pose great challenges. The investors need to conduct three tests which include a named problem, outside laboratory evidence (repeat orders), and a cost test compared to the old approach.

Nanotechnology companies to watch in 2026 and beyond

Four dates will test the thesis. NX Filtration reports full-year results on 9 February 2027. EU member states must pass the wastewater directive into law by 31 July 2027, and producer duties start by 31 December 2028. The EPA still has to settle its PFAS rules. Nanoform aims for its first European launch in 2028.

The verdict

Business Honor examines that The Companies whose customers have to buy, whether by law, by corrosion cost or by clinical need, show the strongest traction. Those still waiting for a market depend on patient money.

The business impact is quieter than the technology suggests. Nanotech rarely shows up as a headline product. It shows up as a membrane in a skid, an additive in a tank, a tablet in a blister pack. That makes it easy to overlook and hard to replace. The real debate is whether investors should back the best science or the demand that regulation protects. Which would you choose?

FAQs

Who are the top small nanotech companies to watch in 2026?

In water: NX Filtration, Innovacarbon and CarboNet. In coatings: Nanophyll, Smallmatek and Integran Technologies. In healthcare: Nanoform and Spago Nanomedical. Check each firm's stage and funding first.

How is nanotechnology in water treatment used?

It shows up in nanofiltration membranes, adsorbent filters and treatment chemicals that remove PFAS, drug residues, dyes and heavy metals. Demand for this water purification technology is growing as the EU requires micropollutant removal.

How does nanotechnology in healthcare help patients?

It can help drugs dissolve and reach their target. Nanoform wants to replace four tablets with one, and Spago Nanomedical is testing a radiotherapy that targets tumors.

What do innovative nanotechnology startups offer in coatings?

Surfaces that resist corrosion, fouling and microbes, which cuts maintenance costs. Corrosion costs about US$2.5 trillion a year worldwide, according to NACE International's IMPACT study.

Are small nanotech companies safe investments?

Not automatically. Several are early-stage or clinical-stage and rely on outside funding, so one trial or one order can swing results. This is not investment advice.